Related Experiment Video
Updated: Jan 22, 2026
07:02
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
Published on: September 14, 2010
13.1K
Recent advances in HIV-associated Kaposi sarcoma
Alessia Dalla Pria1,2, David J Pinato1,2, Margherita Bracchi2
1Imperial College London, London, UK.
F1000Research
|July 13, 2019
Summary
Kaposi sarcoma (KS), an AIDS-defining illness, remains a significant cancer in HIV-positive individuals in sub-Saharan Africa. This review examines KS epidemiology, management, and the potential of immune checkpoint inhibitors for HIV-associated KS treatment.
Area of Science:
- Oncology
- Infectious Diseases
- Immunology
Background:
- Kaposi sarcoma (KS) is a mesenchymal tumor caused by KS-associated herpesvirus and is an AIDS-defining illness.
- While combination anti-retroviral therapy has reduced KS incidence, it remains the most common cancer in people living with HIV in sub-Saharan Africa, causing substantial morbidity and mortality.
Purpose of the Study:
- To review recent epidemiological data on HIV-associated Kaposi sarcoma.
- To discuss current management strategies, unmet needs, and future therapeutic perspectives for HIV-associated KS.
- To emphasize the potential role of immune checkpoint inhibitors in treating HIV-associated KS.
Main Methods:
- Literature review of recent epidemiological studies on Kaposi sarcoma.
- Analysis of current clinical management guidelines and treatment outcomes for HIV-associated KS.
- Exploration of emerging therapeutic targets, including immune checkpoint inhibitors.
Main Results:
- Kaposi sarcoma continues to be a major health concern for people living with HIV in sub-Saharan Africa.
- Significant advancements in treatment have been made, but unmet needs persist in managing HIV-associated KS.
- Immune checkpoint inhibitors show promise as a potential future treatment modality.
Conclusions:
- Despite progress, effective management of HIV-associated Kaposi sarcoma requires ongoing research and improved therapeutic strategies.
- Immune checkpoint inhibitors represent a promising avenue for future treatment development in HIV-associated KS.
- Addressing the persistent burden of Kaposi sarcoma in sub-Saharan Africa is crucial for improving outcomes in HIV-positive populations.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
02:22Overview of Advanced Functional Groups
29.3K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.3K
01:08Sample Preparation for Analysis: Advanced Techniques
1.3K
Accurate analysis of complex samples often requires advanced preparation techniques to achieve reliable and reproducible results. Samples containing inorganic or organic materials can be challenging to dissolve or decompose effectively. Standard sample preparation methods include acid digestion, fusion, dry ashing, and wet digestion.
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
1.3K
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
497
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
497
00:36Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K